This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Shinichi Miyagawa: Innovator in Fibrinogen Preparation
Introduction
Shinichi Miyagawa is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medical materials, particularly through his innovative work on fibrinogen preparations. His research focuses on improving the solubility and usability of fibrinogen in clinical settings.
Latest Patents
Miyagawa holds a patent for a solid fibrinogen preparation. This preparation is designed to have enhanced solubility and can be rapidly prepared for clinical use. The solid fibrinogen composition includes fibrinogen as the main ingredient, along with albumin, a nonionic surfactant, a basic amino acid or its salt, and at least two amino acids or their salts selected from acidic and neutral amino acids. This innovative composition can be held on a medical material to create a supporting material that holds fibrinogen. Furthermore, this supporting material can be combined with thrombin to produce a fibrin adhesive.
Career Highlights
Miyagawa is associated with the Chemo-Sero-Therapeutic Research Institute, where he continues to advance his research in medical applications. His work has the potential to significantly impact clinical practices and improve patient outcomes.
Collaborations
Miyagawa collaborates with esteemed colleagues such as Tatsuya Araki and Hiroshi Kaetsu, contributing to a dynamic research environment that fosters innovation.
Conclusion
Shinichi Miyagawa's contributions to fibrinogen preparation exemplify the intersection of innovation and medical science. His work not only enhances the usability of fibrinogen but also paves the way for advancements in clinical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile